FDA approves heart protection claims for Amgen cholesterol drug

(Reuters) - Amgen Inc can now promote the ability of its potent but expensive cholesterol drug to reduce the risk of heart attacks and strokes, after U.S. health regulators approved adding those benefits to the medicine's prescribing label, the company said on Friday.

from Reuters: Health News http://ift.tt/2jClzGS